English dictionary of cancer terms . 2015.
raloxifene — /rə lokˈsi fēn/ noun A non hormonal drug that mimics the action of oestrogen, used to prevent osteoporosis in postmenopausal women by increasing bone density … Useful english dictionary
Raloxifene — drugbox IUPAC name = [6 hydroxy 2 (4 hydroxyphenyl) benzothiophen 3 yl] [4 [2 (1 piperidyl)ethoxy] phenyl] methanone CAS number = 84449 90 1 ATC prefix = G03 ATC suffix = XC01 PubChem = 5035 DrugBank = APRD00400 C = 28 | H = 27 | N = 1 | O = 4 |… … Wikipedia
raloxifene — n. a drug used to prevent and treat osteoporosis that develops after the menopause. Raloxifene is a selective oestrogen receptor modulator (SERM): it mimics the protective action of oestrogen in the bones without the risk of the adverse effects… … The new mediacal dictionary
raloxifene — noun Etymology: ral (of unknown origin) + oxifene, alteration of oxifen (as in tamoxifen) Date: 1993 a drug used orally in the form of its hydrochloride C28H27NO4S•HCl as prophylaxis against osteoporosis after menopause … New Collegiate Dictionary
raloxifene — noun A drug used in the treatment of osteoporosis … Wiktionary
raloxifene — A selective estrogen receptor modulator (SERM) that has estrogen agonistic effects on bone and lipid metabolism but estrogen antagonistic effects on breast and uterus; used in the prophylaxis of osteoporosis after … Medical dictionary
raloxifene — ra•lox•i•fene [[t]rəˈlɒk səˌfin[/t]] n. pha a drug, C28H27NO4prescribed primarily to prevent postmenopausal osteoporosis … From formal English to slang
raloxifene — /rəˈlɒksəfin/ (say ruh loksuhfeen) noun a SERM used in the treatment of breast cancer and of osteoporosis in menopausal women …
raloxifene hydrochloride — ral·ox·i·fene hy·dro·chlo·ride (ral okґsĭ fēn) a selective estrogen receptor modulator that has estrogenlike effects on bone, increasing bone mineral density, and on lipid metabolism, decreasing total and LDL cholesterol, but not on… … Medical dictionary
Study of Tamoxifen and Raloxifene — The Study of Tamoxifen and Raloxifene or STAR is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in postmenopausal women who are at increased risk of the… … Wikipedia
